‘Groundbreaking’ DNA tests could ‘spot men most likely to fall victim to under-the-radar prostate cance...

radiotherapyCurrent scans often cannot see the cells as they hide in tiny glands – but a man’s genes could give them away.“Armed with this knowledge, we're working out for the first time how to identify these men so we can adjust their treatment.

“We’re also looking at how to spot the early signs of cancer returning in follow-up scans so it can be treated again as quickly and as successfully as possible.”It is not known what causes the disease but age, family history, obesity and being black can all mean you're more at risk.

Prostate Cancer UK is funding the new research into improving how doctors are able to spot this and improve people’s Simon Grieveson, of Prostate Cancer UK, said: “For a man with early-stage prostate cancer, radiotherapy is an extremely effective treatment — and for lots of men it can be curative.“Sadly, however, too many men find out after treatment that their prostate cancer has come back.

“Dr Shortall’s work has the potential to optimise and tailor the way men are treated with radiotherapy and ensure that more men do not see their cancer return.”

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New research highlights combining prostate MRI with a blood test to avoid unnecessary prostate biopsiesMRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests
Source: medical_xpress - 🏆 101. / 51 Read more »

Combining MRI and blood tests to avoid unnecessary prostate biopsiesMRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests.
Source: NewsMedical - 🏆 19. / 71 Read more »

Myths about PSA tests and prostate cancer screeningThe understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate cancer screening, says Andrew Vickers, Ph.D., of Memorial Sloan Kettering Cancer Center (MSK).
Source: medical_xpress - 🏆 101. / 51 Read more »